Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
meeting tags : Ema save search
Many Billions in Plant-Protein Infrastructure Investment Needed to Meet 2030 Demand
Published: 2022-03-17 (Crawled : 14:00) - prnewswire.com
POST | $102.32 0.92% 75K
|
Consumer Non-Durables
|
| O: -0.7%
H: 2.82%
C: 1.97%
HRL | News | $34.235 0.57% 370K
|
Consumer Non-Durables
|
| O: 0.24%
H: 0.87%
C: 0.42%
GIS 4 | $68.91 0.58% 1.1M
|
Consumer Non-Durables
|
| O: -0.06%
H: 1.45%
C: 0.97%
CPB | $43.515 0.47% 380K
|
Consumer Non-Durables
|
| O: 0.09%
H: 0.94%
C: 0.09%
ema
BMG accelerates Google Cloud migration with Rackspace Technology to meet data demands of music consumption boom
Published: 2022-03-17 (Crawled : 09:00) - globenewswire.com
RXT | $1.595 4.93% 310K
|
Technology Services
|
| O: -5.41%
H: 4.67%
C: 4.29%
ema space technology cel spac
Vaccinex, Inc. Announces Upcoming Presentation at the 2022 American Association for Cancer Research Meeting Updating the Phase 1b Segment of the KEYNOTE-B84 Study of Pepinemab in Combination with KEYTRUDA (pembrolizumab) in Patients with Recurrent or Meta
Published: 2022-03-09 (Crawled : 16:20) - ir.vaccinex.com
VCNX | $4.71 -2.69% 6K
|
Health Technology
|
| O: 1.83%
H: 18.92%
C: 17.12%
america ema phase 1b research presentation pepinemab phase 1 keytruda dating cancer vaccine phase 2b
Olema Oncology Announces Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2022
Published: 2022-03-08 (Crawled : 22:00) - globenewswire.com
OLMA | $9.93 -7.28% 210K
|
Health Technology
|
| O: 2.97%
H: 10.42%
C: 8.65%
america ema pos research presentation cancer
Emmaus Life Sciences' Real World Data on Endari® Accepted for E-Poster at the 62nd Annual Scientific Meeting of the British Society for Haematology
Published: 2022-03-04 (Crawled : 19:00) - biospace.com/
EMMA | $0.1138 300
|
Professional, Scientific, and T...
|
| O: 0.0%
H: 0.71%
C: -0.71%
endari ema pos life science
Pressure is on to Fund Uranium Mining Enabling Miners to Produce Enough to Meet Demand
Published: 2022-01-18 (Crawled : 15:30) - prnewswire.com
RIO | $66.88 0.15% 1.8M
|
Non-Energy Minerals
|
| O: -0.92%
H: 1.62%
C: 1.37%
CCJ | $48.68 0.56% 710K
|
Non-Energy Minerals
|
| O: -0.22%
H: 0.0%
C: 0.0%
UEC | $6.875 -0.07% 1.4M
|
Non-Energy Minerals
|
| O: -0.6%
H: 0.91%
C: -4.24%
UUUU | $5.835 1.3% 1M
|
Non-Energy Minerals
|
| O: -0.56%
H: 0.42%
C: -6.33%
ema uranium
BIONIK Laboratories InMotion® Robotics Technology Meets the Recovery Demands from an Increase of Stroke Patients Brought on by Severe Cases of COVID-19
Published: 2021-12-17 (Crawled : 14:00) - biospace.com/
BNKL | $0.1 -39.39% 1.8K
|
Manufacturing
|
| O: 0.0%
H: 0.0%
C: -1.55%
covid-19 inmotion ema technology covid stroke
BioLineRx Provides Highlights from Oral Presentation Delivered at the 63rd American Society of Hematology (ASH) Annual Meeting & Exposition
Published: 2021-12-17 (Crawled : 13:00) - biospace.com/
BLRX | News | $0.6214 73K
|
Health Technology
|
| O: -1.83%
H: 9.35%
C: 7.94%
ema liver presentation
BioLineRx Provides Highlights from Oral Presentation Delivered at the 63rd American Society of Hematology (ASH) Annual Meeting & Exposition
Published: 2021-12-17 (Crawled : 12:30) - prnewswire.com
BLRX | News | $0.6214 73K
|
Health Technology
|
| O: -1.83%
H: 9.35%
C: 7.94%
ema liver presentation
Century Therapeutics Announces Presentation of Data at the 63rd American Society of Hematology Annual Meeting and Provides Pipeline Updates
Published: 2021-12-16 (Crawled : 12:00) - globenewswire.com
IPSC | $2.965 4.4% 78K
|
Professional, Scientific, and T...
|
| O: 2.52%
H: 0.0%
C: 0.0%
ema therapeutics presentation
Oncolytics Biotech® Announces the Presentation of Preclinical Data Demonstrating the Synergistic Anti-Leukemic Effects of Pelareorep Combined with Azacitidine at the 2021 American Society of Hematology Annual Meeting
Published: 2021-12-15 (Crawled : 12:30) - prnewswire.com
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: -0.63%
H: 0.64%
C: -1.27%
biotech ema presentation preclinical iot pre-clinical
Geron Reports Presentations at American Society of Hematology Annual Meeting
Published: 2021-12-14 (Crawled : 01:00) - biospace.com/
GERN | $3.795 3.13% 2.1M
|
Health Technology
|
| O: 0.38%
H: 0.0%
C: 0.0%
ema presentation
Lantern Pharma Presents Positive Data on the Effectiveness of LP-284 in Hematologic Cancers at the 63rd American Society of Hematology (ASH) Annual Meeting
Published: 2021-12-14 (Crawled : 20:00) - biospace.com/
LTRN | $5.87 -2.0% 47K
|
Health Technology
|
| O: 0.13%
H: 1.57%
C: -1.77%
lp-284 ema positive cancer
Highlights from American Society of Hematology 2021 Meeting
Published: 2021-12-14 (Crawled : 15:30) - biospace.com/
JNJ | News | $144.86 0.06% 2.8M
|
Health Technology
|
| O: 1.9%
H: 0.0%
C: 0.0%
ema
Emmaus Life Sciences Presents Positive Transfusion Data from a Post-Hoc Analysis of its Phase 3 Clinical Study of Endari® in Patients With Sickle Cell Disease at the 63rd American Society of Hematology (ASH) Annual Meeting
Published: 2021-12-14 (Crawled : 14:30) - biospace.com/
EMMA | $0.1138 300
|
Professional, Scientific, and T...
|
| O: -0.33%
H: 2.65%
C: -2.65%
endari ema transfusion disease cel positive life science phase 3
TG Therapeutics Announces Data from the UNITY-CLL Phase 3 Trial Presented at the 63rd American Society of Hematology (ASH) Annual Meeting
Published: 2021-12-14 (Crawled : 12:30) - globenewswire.com
TGTX | $14.47 4.7% 1.6M
|
Health Technology
|
| O: -5.49%
H: 2.43%
C: -2.68%
ema trial therapeutics phase 3
Atara Biotherapeutics Announces Positive Results from Pivotal Phase 3 Trial (ALLELE) of Tab-cel® at the 63rd American Society of Hematology (ASH) Annual Meeting
Published: 2021-12-14 (Crawled : 06:00) - biospace.com/
ATRA | $0.713 -0.27% 100K
|
Health Technology
|
| O: -4.53%
H: 4.22%
C: 2.01%
cel ema trial therapeutics positive results tab-cel positive results phase 3 iot
ORIC Pharmaceuticals Presents Data Supporting the Therapeutic Potential of ORIC-533 in Multiple Myeloma at the American Society of Hematology (ASH) Annual Meeting
Published: 2021-12-13 (Crawled : 22:00) - biospace.com/
ORIC | $9.84 0.82% 130K
|
Health Technology
|
| O: 1.67%
H: 0.0%
C: 0.0%
oric-533 ema als potential
Corrected: Keros Therapeutics Presents Clinical Trial and Preclinical Study Results from its KER-050 Program and Preclinical Data from its ALK2 Inhibitor Program at the 63rd American Society of Hematology Annual Meeting and Exposition
Published: 2021-12-13 (Crawled : 21:00) - globenewswire.com
KROS | $60.05 1.32% 100K
|
Health Technology
|
| O: -9.67%
H: 1.03%
C: 0.73%
ker-050 ema trial therapeutics preclinical results pre-clinical
NextCure and Collaborators Provide Data on Targets in Development at American Society of Hematology Annual Meeting
Published: 2021-12-13 (Crawled : 21:00) - globenewswire.com
NXTC | $1.57 3.97% 28K
|
Health Technology
|
| O: -1.96%
H: 0.0%
C: 0.0%
ema collaboration
Gainers vs Losers
| 80% | 20% |
Top 10 Gainers
AGBA | $0.7995 99.88% 73M
|
Finance
BPTH | $6.21 91.67% 58M
|
Health Technology
INVO | $1.36 78.95% 3.6M
|
Health Technology
TIRX | $0.8231 69.78% 54M
|
ISPC | $0.307 44.13% 3.6M
|
Professional, Scientific, and T...
SINT | $0.0519 39.14% 350M
|
Health Technology
XPON | $2.63 36.27% 8.4M
|
ALRN | $5.53 30.12% 250K
|
Health Technology
VTNR S | $1.26 28.68% 9.1M
|
Industrial Services
HOLO | $2.86 27.68% 28M
|
Your saved searches
Save your searches and get alerts when important news are released.